Pronóstico del mercado de diagnóstico de la apnea del sueño en Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por producto (dispositivo de polisomnografía (PSG), dispositivos de prueba del sueño en el hogar, oxímetro, dispositivo de monitoreo de actigrafía y dispositivo de detección de apnea del sueño) y usuario final (hospitales) y laboratorios del sueño y entornos de atención domiciliaria)

TIPRE00026637 | Pages: 113 | Medical Device | Jan 2022 | Type: Regional | Status: Published

El mercado del diagnóstico de la apnea del sueño en Oriente Medio y Asia. Se espera que África crezca de 20,88 millones de dólares en 2021 a 27,01 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 3,7 % entre 2021 y 2028.

Los avances en el conocimiento de la biología y la ingeniería han mejorado igualmente los diversos dispositivos médicos, como la polisomnografía (PSG). ), dispositivos de prueba del sueño en el hogar y otros. En los últimos años, muchos actores de la industria han creado tipos innovadores de dispositivos de diagnóstico de la apnea del sueño. Por ejemplo, en julio de 2019, CleveMed, una empresa líder en pruebas domiciliarias de apnea del sueño, anuncia el lanzamiento de un nuevo servicio integral de atención del sueño diseñado para pacientes con trastornos del sueño en el mercado privado de pago. Además, en septiembre de 2019, Koninklijke Philips NV lanzó Philips NightBalance, un dispositivo de terapia de posición para dormir con receta diseñado para pacientes con AOS posicional. Es probable que el producto sea un tratamiento no inferior a la presión positiva continua en las vías respiratorias (CPAP) y demuestra altas tasas de cumplimiento entre los pacientes con AOS posicional. Con estos avances, el mercado está registrando un crecimiento tremendo.

 

El coronavirus ha tenido un impacto significativo en Medio Oriente y Asia. África. Irán fue una de las primeras víctimas de la pandemia, y ya en marzo de 2020 se notificaron casos mortales. Los países africanos vieron tres oleadas de la pandemia, con algunos valores atípicos. Sin embargo, debido a la insuficiencia de los sistemas de diagnóstico y notificación en algunos países, resulta difícil realizar un examen comparable entre países de la intensidad de la infección. La frecuencia relativa de las pruebas se puede utilizar como indicador indirecto del rendimiento del sistema de diagnóstico. Los Emiratos Árabes Unidos (EAU) y Bahréin han sido líderes regionales en términos de pruebas, superando a algunas economías avanzadas. La apnea obstructiva del sueño y otros trastornos del sueño tienen comorbilidades con la infección por coronavirus 2 del síndrome respiratorio agudo severo, que están relacionadas con malos resultados. Sin embargo, se comprende poco la prevalencia de la apnea obstructiva del sueño y su asociación con los resultados en pacientes con COVID-19, y la importancia de otros trastornos del sueño es incierta. Parece haber un vínculo claro entre el sobrepeso o la obesidad y la probabilidad de hospitalización y necesidad de tratamiento en unidades de cuidados intensivos para personas con la enfermedad por coronavirus 2019 (COVID-19), causada por el síndrome respiratorio agudo severo coronavirus 2 (SARS- CoV-2) (UCI). Según una nueva investigación, las personas obesas menores de 60 años tienen más probabilidades de ser hospitalizadas. Las tasas de prevalencia de la obesidad se encuentran entre las más altas del mundo en Oriente Medio. Dado el aumento exponencial de la incidencia de la obesidad, saber cómo la obesidad aumenta el riesgo de infección grave por COVID-19 es crucial para desarrollar tratamientos intervencionistas y preventivos eficaces para este nuevo coronavirus.

 

Con las nuevas características y tecnologías, los proveedores pueden atraer nuevos clientes y ampliar su presencia en los mercados emergentes. Es probable que este factor impulse a Oriente Medio y Asia. Mercado africano de diagnóstico de la apnea del sueño. Medio Oriente y Asia Se espera que el mercado africano de diagnóstico de la apnea del sueño crezca a una buena CAGR durante el período de pronóstico.

 Oriente Medio y África. Ingresos del mercado de diagnóstico de apnea del sueño en África y pronóstico hasta 2028 (millones de dólares estadounidenses)

 

Medio Oriente y Asia. Segmentación del mercado de diagnóstico de apnea del sueño en África

Medio Oriente y Asia Mercado africano de diagnóstico de la apnea del sueño: Por producto

  • Dispositivo de polisomnografía (PSG)
  • Dispositivos de prueba del sueño en el hogar
  • Oxímetro
  • Oxímetro de punta
  • De mano Oxímetro
  • Oxímetro de muñeca
  • Oxímetro de mesa
  • Dispositivo de monitorización de actigrafía
  • Dispositivo de detección de apnea del sueño

Oriente Medio &erio; Mercado africano de diagnóstico de la apnea del sueño: Por Usuario final

  • Hospitales y laboratorios del sueño
  • Inicio Entornos de atención

Oriente Medio y África Mercado africano de diagnóstico de la apnea del sueño: Por país

  • Sudáfrica
  • Arabia Saudita  
  • EAU
  • Resto de MEA

Medio Oriente y Asia Mercado africano de diagnóstico de la apnea del sueño: Empresas mencionadas

  • ResMed Inc.
  • Nihon Kohden Corporation LLC
  • SOMNOmedics GmbH
  • Cleveland Medical Devices Inc.  
  • Koninklijke Philips NV
  • Natus Medical Incorporated
  • Itamar Medical Ltd.
  • Compumedics Limited

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Sleep Apnea Diagnostics Market – By Product

1.3.2        Middle East & Africa Sleep Apnea Diagnostics Market – By End User

1.3.3        Middle East & Africa Sleep Apnea Diagnostics Market – By Country

2.           Middle East & Africa Sleep Apnea Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Sleep Apnea Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Sleep Apnea Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Strengthen Prevalence of Sleep Apnea

5.1.2        Expanding Technological Developments

5.1.3        Up-raising Geriatric Population

5.2         Market Restraints

5.2.1        Expensive Cost of Diagnosis of Sleep Apnea

5.3         Future Trends

5.3.1        Scaling Scope of Telemedicine

5.4         Impact Analysis

6.           Middle East & Africa Sleep Apnea Diagnostics Market Analysis

6.1         Middle East & Africa Sleep Apnea Diagnostics Market Revenue Forecast and Analysis

7.           Middle East & Africa Sleep Apnea Diagnostics Market Analysis – By Product

7.1         Overview

7.2         Middle East & Africa Sleep Apnea Diagnostics Market Share, by Product, 2021 and 2028 (%)

7.3         Polysomnography Devices

7.3.1        Overview

7.3.2        Polysomnography Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Home Sleep Testing Devices

7.4.1        Overview

7.4.2        Home Sleep Testing Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Oximeters

7.5.1        Overview

7.5.2        Oximeters: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.5.3        Finger Tip Oximeter

7.5.3.1          Overview

7.5.3.2          Finger Tip Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.5.4        Handheld Oximeter

7.5.4.1          Overview

7.5.4.2          Handheld Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.5.5        Wrist-Worn Oximeter

7.5.5.1          Overview

7.5.5.2          Wrist-worn Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.5.6        Tabletop Oximeter

7.5.6.1          Overview

7.5.6.2          Tabletop Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.6         Actigraphy Monitoring Device

7.6.1        Overview

7.6.2        Actigraphy Monitoring Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

7.7         Sleep Apnea Screening Device

7.7.1        Overview

7.7.2        Sleep Apnea Screening Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Sleep Apnea Diagnostics Market Analysis – By End User

8.1         Overview

8.2         Middle East & Africa Sleep Apnea Diagnostics Market Share, by End User, 2021 and 2028 (%)

8.3         Home Care Settings

8.3.1        Overview

8.3.2        Home Care Settings: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Hospital and Sleep Laboratories

8.4.1        Overview

8.4.2        Hospital and Sleep Laboratories: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Sleep Apnea Diagnostics Market – Country Analysis

9.1         Overview

9.1.1        Middle East & Africa: Sleep Apnea Diagnostics Market, by Country, 2021& 2028 (%)

9.1.1.1          Saudi Arabia: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1          Saudi Arabia: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2          Saudi Arabia: Sleep Apnea Diagnostics Market, by Product- Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2.1        Saudi Arabia: Sleep Apnea Diagnostics Market, by Oximeter - Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3          Saudi Arabia: Sleep Apnea Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

9.1.1.2          South Africa: Sleep Apnea Diagnostics Market- Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1          South Africa: Sleep Apnea Diagnostics Market Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2          South Africa: Sleep Apnea Diagnostics Market, by Product- Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2.1        South Africa : Sleep Apnea Diagnostics Market, by Oximeter - Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3          South Africa: Sleep Apnea Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

9.1.1.3          UAE: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          UAE: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2          UAE: Sleep Apnea Diagnostics Market, by Product- Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2.1        UAE: Sleep Apnea Diagnostics Market, by Oximeter- Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3          UAE: Sleep Apnea Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

9.1.1.4          Rest of MEA: Sleep Apnea Diagnostics Market- Revenue and Forecast to 2028 (USD Million)

9.1.1.4.1          Rest of MEA: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.1.1.4.2          Rest of MEA: Sleep Apnea Diagnostics Market, by Product- Revenue and Forecast to 2028 (USD Million)

9.1.1.4.2.1        Rest of MEA: Sleep Apnea Diagnostics Market, by Oximeter - Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3          Rest of MEA: Sleep Apnea Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on Middle East & Africa Sleep Apnea Diagnostics Market

10.1      Impact Assessment of COVID-19 Pandemic

11.        Middle East & Africa Sleep Apnea Diagnostics Market –Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      ResMed Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Nihon Kohden Corporation

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      SOMNOmedics GmbH

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Cleveland Medical Devices Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Koninklijke Philips N.V.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Natus Medical Incorporated

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Itamar Medical Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Compumedics Limited

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East & Africa Sleep Apnea Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Sleep Apnea Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             South Africa Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             South Africa Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)

Table 7.             South Africa Sleep Apnea Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE Sleep Apnea Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of MEA Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of MEA Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of MEA Sleep Apnea Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Recent organic developments in the Sleep Apnea Diagnostics Market

Table 15.          Inorganic Developments

Table 16.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           Middle East & Africa Sleep Apnea Diagnostics Market Segmentation

Figure 2.           Middle East & Africa Sleep Apnea Diagnostics Market Segmentation, By Country

Figure 3.           Middle East & Africa Sleep Apnea Diagnostics Market Overview

Figure 4.           Polysomnography (PSG) Device Held the Largest Share of the Product Segment in Middle East & Africa Sleep Apnea Diagnostics Market

Figure 5.           South Africa to Show Significant Growth during Forecast Period

Figure 6.           Middle East & Africa Sleep Apnea Diagnostics Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Sleep Apnea Diagnostics Market Impact Analysis of Driver and Restraints

Figure 9.           Middle East & Africa Sleep Apnea Diagnostics Market– Revenue Forecast and Analysis to 2028

Figure 10.        Middle East & Africa Sleep Apnea Diagnostics Market Share, by Product, 2021 and 2028 (%)

Figure 11.        Polysomnography Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Home Sleep Testing Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Oximeters: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Finger Tip Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Handheld Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Wrist-worn Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Tabletop Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Actigraphy Monitoring Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Sleep Apnea Screening Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Middle East & Africa Sleep Apnea Diagnostics Market Share, by End User, 2021 and 2028 (%)

Figure 21.        Home Care Settings: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Hospital and Sleep Laboratories: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Middle East & Africa: Sleep Apnea Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 24.        Middle East & Africa: Sleep Apnea Diagnostics Market, by Country, 2021& 2028 (%)

Figure 25.        Saudi Arabia: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 26.        South Africa: Sleep Apnea Diagnostics Market Market– Revenue and Forecast to 2028 (USD Million)

Figure 27.        UAE: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 28.        Rest of MEA: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 29.        Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets

  1. ResMed Inc.
  2. Nihon Kohden Corporation LLC
  3. SOMNOmedics GmbH
  4. Cleveland Medical Devices Inc. 
  5. Koninklijke Philips N.V.
  6. Natus Medical Incorporated
  7. Itamar Medical Ltd.
  8. Compumedics Limited
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa sleep apnea diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa sleep apnea diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the sleep apnea diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000